103 research outputs found
Towards surface quantum optics with Bose-Einstein condensates in evanescent waves
We present a surface trap which allows for studying the coherent interaction
of ultracold atoms with evanescent waves. The trap combines a magnetic Joffe
trap with a repulsive evanescent dipole potential. The position of the magnetic
trap can be controlled with high precision which makes it possible to move
ultracold atoms to the surface of a glass prism in a controlled way. The
optical potential of the evanescent wave compensates for the strong attractive
van der Waals forces and generates a potential barrier at only a few hundred
nanometers from the surface. The trap is tested with Rb Bose-Einstein
condensates (BEC), which are stably positioned at distances from the surfaces
below one micrometer
Non-destructive, dynamic detectors for Bose-Einstein condensates
We propose and analyze a series of non-destructive, dynamic detectors for
Bose-Einstein condensates based on photo-detectors operating at the shot noise
limit. These detectors are compatible with real time feedback to the
condensate. The signal to noise ratio of different detection schemes are
compared subject to the constraint of minimal heating due to photon absorption
and spontaneous emission. This constraint leads to different optimal operating
points for interference-based schemes. We find the somewhat counter-intuitive
result that without the presence of a cavity, interferometry causes as much
destruction as absorption for optically thin clouds. For optically thick
clouds, cavity-free interferometry is superior to absorption, but it still
cannot be made arbitrarily non-destructive . We propose a cavity-based
measurement of atomic density which can in principle be made arbitrarily
non-destructive for a given signal to noise ratio
Dynamics of Dipolar Spinor Condensates
We study the semiclassical dynamics of a spinor condensate with the magnetic
dipole-dipole interaction included. The time evolution of the population
imbalance and the relative phase among different spin components depends
greatly on the relative strength of interactions as well as on the initial
conditions. The interplay of spin exchange and dipole-dipole interaction makes
it possible to manipulate the atomic population on different components,
leading to the phenomena of spontaneous magnetization and Macroscopic Quantum
Self Trapping. Simple estimate demonstrates that these effects are accessible
and controllable by modifying the geometry of the trapping potential.Comment: 13 pages,3 figure
Atazanavir and darunavir in pregnant women with HIV: Evaluation of laboratory and clinical outcomes from an observational national study
Background: Atazanavir and darunavir represent the main HIV PIs recommended in pregnancy, but comparativedata in pregnant women are limited.We assessed the safety and activity profile of these two drugs in pregnancyusing data from a national observational study.Methods: Women with atazanavir or darunavir exposure in pregnancy were evaluated for laboratory measuresand main pregnancy outcomes (e.g. preterm delivery, low birthweight, non-elective caesarean section and neonatalgestational age-adjusted birthweight Z-score).Results: Final analysis included 500 pregnancies with either atazanavir (n"409) or darunavir (n"91) exposure.No differences in pregnancy outcomes, weight gain in pregnancy, drug discontinuations, undetectable HIV-RNA,haemoglobin, ALT, total cholesterol, HDL cholesterol and LDL cholesterol were observed between the twogroups. At third trimester, exposure to darunavir was associated with higher levels of plasma triglycerides(median 235.5 versus 179 mg/dL; P"0.032) and a higher total cholesterol/HDL cholesterol ratio (median 4.03versus 3.27; P"0.028) and exposure to atazanavir was associated with higher levels of plasma bilirubin (1.54versus 0.32 mg/dL; P<0.001).Conclusions: In this observational study, the two main HIV PIs currently recommended by perinatal guidelinesshowed similar safety and activity in pregnancy, with no evidence of differences between the two drugs in termsof main pregnancy outcomes. Based on the minor differences observed in laboratory measures, prescribingphysicians might prefer either drug in some particular situations where the different impacts of treatment onlipid profile and bilirubin may have clinical relevance
Pregnancy outcomes and cytomegalovirus DNAaemia in HIV infected pregnant women with CMV
no disponibil
Rate , correlates and outcomes of repeat pregnancy in HIV-infected women
Objectives: The aim of the study was to assess the rate, determinants, and outcomes of repeat pregnancies in women with HIV infection. Methods: Data from a national study of pregnant women with HIV infection were used. Main outcomes were preterm delivery, low birth weight, CD4 cell count and HIV plasma viral load. Results: The rate of repeat pregnancy among 3007 women was 16.2%. Women with a repeat pregnancy were on average younger than those with a single pregnancy (median age 30 vs. 33 years, respectively), more recently diagnosed with HIV infection (median time since diagnosis 25 vs. 51 months, respectively), and more frequently of foreign origin [odds ratio (OR) 1.36; 95% confidence interval (CI) 1.10–1.68], diagnosed with HIV infection in the current pregnancy (OR: 1.69; 95% CI: 1.35–2.11), and at their first pregnancy (OR: 1.33; 95% CI: 1.06–1.66). In women with sequential pregnancies, compared with the first pregnancy, several outcomes showed a significant improvement in the second pregnancy, with a higher rate of antiretroviral treatment at conception (39.0 vs. 65.4%, respectively), better median maternal weight at the start of pregnancy (60 vs. 61 kg, respectively), a higher rate of end-of-pregnancy undetectable HIV RNA (60.7 vs. 71.6%, respectively), a higher median birth weight (2815 vs. 2885 g, respectively), lower rates of preterm delivery (23.0 vs. 17.7%, respectively) and of low birth weight (23.4 vs. 15.4%, respectively), and a higher median CD4 cell count (+47 cells/μL), with almost no clinical progression to Centers for Disease Control and Prevention stage C (CDC-C) HIV disease (0.3%). The second pregnancy was significantly more likely to end in voluntary termination than the first pregnancy (11.4 vs. 6.1%, respectively). Conclusions: Younger and foreign women were more likely to have a repeat pregnancy; in women with sequential pregnancies, the second pregnancy was characterized by a significant improvement in several outcomes, suggesting that women with HIV infection who desire multiple children may proceed safely and confidently with subsequent pregnancies
Time-Course of Changes in Inflammatory Response after Whole-Body Cryotherapy Multi Exposures following Severe Exercise
The objectives of the present investigation was to analyze the effect of two different recovery modalities on classical markers of exercise-induced muscle damage (EIMD) and inflammation obtained after a simulated trail running race. Endurance trained males (n = 11) completed two experimental trials separated by 1 month in a randomized crossover design; one trial involved passive recovery (PAS), the other a specific whole body cryotherapy (WBC) for 96 h post-exercise (repeated each day). For each trial, subjects performed a 48 min running treadmill exercise followed by PAS or WBC. The Interleukin (IL) -1 (IL-1), IL-6, IL-10, tumor necrosis factor alpha (TNF-α), protein C-reactive (CRP) and white blood cells count were measured at rest, immediately post-exercise, and at 24, 48, 72, 96 h in post-exercise recovery. A significant time effect was observed to characterize an inflammatory state (Pre vs. Post) following the exercise bout in all conditions (p<0.05). Indeed, IL-1β (Post 1 h) and CRP (Post 24 h) levels decreased and IL-1ra (Post 1 h) increased following WBC when compared to PAS. In WBC condition (p<0.05), TNF-α, IL-10 and IL-6 remain unchanged compared to PAS condition. Overall, the results indicated that the WBC was effective in reducing the inflammatory process. These results may be explained by vasoconstriction at muscular level, and both the decrease in cytokines activity pro-inflammatory, and increase in cytokines anti-inflammatory
Is "option B+" also being adopted in pregnant women in high-income countries? Temporal trends from a national study in Italy
no disponibil
Good prenatal detection rate of major birth defects in HIV-infected pregnant women in Italy
What's already known about this topic? Exposure to antiretroviral treatment in pregnancy does not seem to increase the risk of birth defects, but there is no information on the rate of prenatal detection of such defects. What does this study adds? We provide for the first time, in a national case series, information about prenatal detection rate in women with HIV (51.6% for any major defect, 66.7% for chromosomal abnormalities, and 85% for severe structural defect
- …